Pfizer's Strategic Appointment: Former FDA Director Takes the Helm as Chief Medical Officer
Pfizer appoints Patrizia Cavazzoni as chief medical officer, the U.S. delays the definition of 'healthy' on labels, issues with Wegovy and Ozempic's drug shortages lead to lawsuits, new outbreaks of listeria are under investigation,
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
But the direct-to-consumer ad didn't come from Palo Alto-based Bridge Bio (Nasdaq: BBIO); instead it was produced by Pfizer ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
GlobalData on MSN22h
Pfizer sets sights on Summit’s bispecific in combo with its ADCsPfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summit’s ivonescimab in combination with several ...
SMMT's Q4 results meet estimates. The company signs a deal with Pfizer that expands ivonescimab's development beyond the NSCLC indication.
The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback